Prospects for Enhancing Efficacy of Radioimmunotherapy - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Book Sections Year : 2018

Prospects for Enhancing Efficacy of Radioimmunotherapy


Radioimmunotherapy has been in use for more than 20 years and has progressed significantly since its efficacy has first been demonstrated in hematology. Yet it still has limitations that prevent its large-scale clinical use. This chapter reviews recent developments to overcome these limitations including new antibody specifici-ties, pretargeting methods, fractionated injections, and the use of alpha emitters. Immuno-PET is also likely to assist in selecting patients for radioimmunotherapy, optimizing injected activities, and noninvasively monitoring therapy efficacy.


Embargoed file
Embargoed file
Visibility date is undetermined

Dates and versions

inserm-02315459 , version 1 (14-10-2019)



Clément Bailly, Caroline Bodet-Milin, François Guérard, Caroline Rousseau, Michel Chérel, et al.. Prospects for Enhancing Efficacy of Radioimmunotherapy. Resistance to Ibritumomab in Lymphoma, pp.139-153, 2018, ⟨10.1007/978-3-319-78238-6_10⟩. ⟨inserm-02315459⟩
46 View
7 Download



Gmail Facebook X LinkedIn More